1. Home
  2. HRTX

HRTX

Heron Therapeutics Inc.

Logo Heron Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 11:08am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Founded: 1983 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 416.4M IPO Year: 1987
Target Price: $5.00 AVG Volume (30 days): 2.6M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.80 EPS Growth: N/A
52 Week Low/High: $0.50 - $3.22 Next Earning Date: 05-09-2024
Revenue: $127,044,000 Revenue Growth: 17.99%
Revenue Growth (this year): 17.16% Revenue Growth (next year): 20.26%

Share on Social Networks: